MetaCap

Emergent BioSolutions (EBS) News

NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.05-0.10 (-1.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EBS news summary

We found 4 recent headlines mentioning Emergent BioSolutions (EBS): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Business Wire. For price context, EBS is down 1.94% at $5.05. The most recent story, "Emergent BioSolutions: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 3, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Emergent BioSolutions headlines

Compare EBS